<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Very little is known about any interaction between <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) and various hypercoagulable disorders that have been associated with cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Percutaneous <z:mp ids='MP_0004225'>PFO</z:mp> closure for secondary prevention of paradoxical thromboembolization is receiving increasing attention </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0100724'>Hypercoagulability</z:hpo> may affect the potential risks and expected benefits of percutaneous <z:mp ids='MP_0004225'>PFO</z:mp> closure </plain></SENT>
<SENT sid="3" pm="."><plain>Consecutive patients undergoing percutaneous <z:mp ids='MP_0004225'>PFO</z:mp> closure at a single center were screened for the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, elevated <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a), <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, and <z:hpo ids='HP_0011901'>dysfibrinogenemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Sixteen of 34 patients (47%) with complete arterial <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> screening had laboratory evidence of arterial <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Thirteen of these patients (38%) had <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> appear to be common in patients referred for percutaneous <z:mp ids='MP_0004225'>PFO</z:mp> closure for secondary prevention of systemic <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Thorough testing based on established recommendations is warranted </plain></SENT>
<SENT sid="8" pm="."><plain>Further studies are needed regarding the interaction between <z:mp ids='MP_0004225'>PFO</z:mp> and various hypercoagulable disorders that have been associated with cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>